regulators' data request means painful wait for MS sufferers23rd July 2007
The Medicines and Healthcare Regulatory Agency (MHRA) met last week to discuss Sativex, a medicinal form of cannabis. It decided more clinical data was needed before the drug could be approved for treating muscle stiffness in MS patients.
Share this page
There are no comments for this article, be the first to comment!
Post your comment
Only registered users can comment. Fill in your e-mail address for quick registration.
Title: regulators' data request means painful wait for MS sufferers
Author: Anne Waller
Article Id: 3538
Date Added: 23rd Jul 2007